Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
2.060
-0.030 (-1.44%)
At close: Mar 27, 2025, 4:00 PM
2.051
-0.009 (-0.44%)
Pre-market: Mar 28, 2025, 8:10 AM EDT
Nexalin Technology Employees
Nexalin Technology had 6 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$28,120
Profits / Employee
-$1,267,864
Market Cap
27.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | 0 | - |
| Dec 31, 2023 | 6 | 0 | - |
| Dec 31, 2022 | 6 | -4 | -40.00% |
| Dec 31, 2021 | 10 | 6 | 150.00% |
| Dec 31, 2020 | 4 | - | - |
NXL News
- 1 day ago - Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3 - GlobeNewsWire
- 24 days ago - Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders - GlobeNewsWire
- 27 days ago - Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB Approval - GlobeNewsWire
- 4 weeks ago - Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board - GlobeNewsWire
- 5 weeks ago - Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment - GlobeNewsWire
- 6 weeks ago - Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition - GlobeNewsWire
- 7 weeks ago - Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study - GlobeNewsWire
- 2 months ago - Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session, Today, January 23 - GlobeNewsWire